SIASUN(SZ:300024) Zhi Tong Cai Jing·2025-06-29 23:30Group 1: Neuralink's Developments - Neuralink has showcased its latest research and product development, with 7 participants currently using the device, including 4 spinal cord injury patients and 3 ALS patients, averaging 50 hours of use per week, with peaks exceeding 100 hours [1] - Elon Musk stated that future advancements may allow individuals to fully control a robot through Neuralink, emphasizing the creation of a universal brain input-output technology that does not harm the brain [1] - Musk believes that a high-bandwidth brain-machine interface is crucial for aligning human collective will with artificial intelligence, thereby mitigating potential survival risks [1] Group 2: Market and Financial Insights - In June, Neuralink completed a $650 million Series E funding round, with major investors including Sequoia Capital and others, aimed at accelerating the adoption of brain-machine interface technology among patients [2] - The global brain-machine interface market is projected to grow at a compound annual growth rate of 25.22%, reaching $7.63 billion from 2025 to 2029 [2] Group 3: Competitive Landscape - The competition in the brain-machine interface industry is intensifying, with companies like Synchron and Precision Neuroscience making significant advancements and funding [3] - The medical rehabilitation sector is identified as a key application area for brain-machine interface technology, particularly for paralyzed patients seeking to regain mobility [3] - Non-invasive brain-machine interfaces currently dominate the market, accounting for 86% of the total market share, while invasive interfaces present significant potential [3] Group 4: Related Companies - Heartway Medical-B has successfully completed animal trials for China's first invasive brain-machine interface, with a reported revenue of RMB 278 million for the year ending December 31, 2024, reflecting a 19.6% increase [4] - Nanjing Panda Electronics is developing a multimodal human-machine interaction system based on brain-machine interface technology as part of a key research project in Jiangsu Province [4] - Microneuroscience is a leading company in the domestic neuro-interventional medical device sector, maintaining the top market share in China [5]